Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001055726-25-000002
Filing Date
2025-02-28
Accepted
2025-02-28 18:05:29
Documents
1
Period of Report
2025-02-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740783922.html 4  
1 FORM 4 wk-form4_1740783922.xml 4 18223
  Complete submission text file 0001055726-25-000002.txt   19883
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Issuer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
KIES PETER (Reporting) CIK: 0001259780 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14888 | Film No.: 25692727